Methods for treating or inhibiting thromboembolic disorders or for inhibiting coagulation
AssigneeLife Sciences Research Partners
InventorsJean-Marie Saint-Remy, Marc Jacquemin
Life of this patent
Estimating the term…
Loading patent…
AssigneeLife Sciences Research Partners
InventorsJean-Marie Saint-Remy, Marc Jacquemin
Estimating the term…
The present invention discloses inhibitory antibodies against Factor VIII with modified glycosylation, either by enzymatic deglycosylation or by site directed mutagenesis. Said antibodies with modified glycosylation have equal affinity for FVIII but show different inhibiting properties. The use of one or a mixture of said antibodies allow modulation of the inhibition of factor VIII to levels between 40 and 95%. The present invention further discloses pharmaceutical compositions comprising inhibitory antibodies against Factor VIII with modified glycosylation, combinations of these antibodies and methods for treating haemostasis disorders using said antibodies and antibody mixtures.
A method for treatment of a thromboembolic disorder or for inhibition of coagulation, said method comprising administering an effective dose of an inhibitory antibody against Factor VIII or fragment thereof comprising the immunoglobulin variable light chain CDR1, CDR2 and CDR3 regions depicted in SEQ ID NO:
Dependencies are inferred from the claim text.